Contact
searchSearch
HMP Global
Login

Schizophrenia News

Podcasts
New Mechanisms of Action in Psychiatry With Dr Craig Chepke
09/14/2022
In this podcast excerpt, Craig Chepke, MD, FAPA, psychiatrist and medical director at Excel Psychiatric Associates in Huntersville, North Carolina, discusses the new mechanisms of action (MOAs) that could help to improve patient care in the...
In this podcast excerpt, Craig Chepke, MD, FAPA, psychiatrist and medical director at Excel Psychiatric Associates in Huntersville, North Carolina, discusses the new mechanisms of action (MOAs) that could help to improve patient care in the...
In this podcast excerpt, Craig...
09/14/2022
Psych Congress Network
Podcasts
Case Managers, Telepsychiatry Offer Consistency in Schizophrenia Treatment
08/24/2022
Amber Hoberg, NP, discusses meeting her patients with schizophrenia "where they are" to provide treatment.
Amber Hoberg, NP, discusses meeting her patients with schizophrenia "where they are" to provide treatment.
Amber Hoberg, NP, discusses...
08/24/2022
Psych Congress Network
Podcasts
How TAAR1 Agonists Might Be Used in Schizophrenia Treatment, With Dr Leslie Citrome
08/02/2022
In this podcast, Psych Congress Network's Schizophrenia Section Editor Leslie L. Citrome, MD, MPH, answers questions about the potential uses of TAAR1 agonists in the treatment of schizophrenia. Andrew Penn, MS, PMHNP, moderates.
In this podcast, Psych Congress Network's Schizophrenia Section Editor Leslie L. Citrome, MD, MPH, answers questions about the potential uses of TAAR1 agonists in the treatment of schizophrenia. Andrew Penn, MS, PMHNP, moderates.
In this podcast, Psych Congress...
08/02/2022
Psych Congress Network
News
Risk of COVID-19 Death Nearly 4 Times Higher in People with Schizophrenia
01/06/2022
Jolynn Tumolo
People with schizophrenia had higher odds of dying from COVID-19 but had significantly lower rates of testing positive for COVID-19 compared with the general population.
People with schizophrenia had higher odds of dying from COVID-19 but had significantly lower rates of testing positive for COVID-19 compared with the general population.
People with schizophrenia had...
01/06/2022
Psych Congress Network
News
Large Study Implicates 10 Genes in Schizophrenia Development
12/02/2019
In a study incorporating genetic data from more than 125,000 people, researchers have implicated 10 new genes in the development of schizophrenia.
In a study incorporating genetic data from more than 125,000 people, researchers have implicated 10 new genes in the development of schizophrenia.
In a study incorporating genetic...
12/02/2019
Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Sign Up

Psych Congress Network Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use